The Centers for Disease Control and Prevention May 8 released an analysis that found declines in hospitalizations for infants infected with respiratory syncytial virus during the 2024-2025 RSV season.

Infant hospitalizations due to respiratory syncytial virus (RSV) infections in the United States dropped as much as 43% last year compared to previous years, following the widespread availability of ...

You’ve worked extensively on respiratory syncytial virus (RSV) and influenza. What are the key differences in how the immune ...

Experts have pointed to RSV vaccine campaigns as a possible reason why. A separate CDC report shows that infant hospitalizations in the 2024-25 respiratory virus season were more than 40% lower than ...

A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...

Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...

The ancestor of the virus that causes COVID-19 left its point of origin in Western China or Northern Laos just several years ...

The overall uptake of RSV vaccine is low during its first season in those aged 60 years or older in the United States. The ...

The health and human services secretary, Robert F. Kennedy Jr., is known for his criticism of advisory panels, most recently ...

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

The U.S. Department of Health and Human Services and the National Institutes of Health announced a new initiative called ...

The U.S. Department of Health and Human Services (HHS), in collaboration with the National Institutes of Health (NIH), has ...